Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is J  [Clear All Filters]
2021
Lawson H, Sepulveda C, van de Lagemaat LN, Durko J, Barile M, Tavosanis A, Georges E, Shmakova A, Timms P, Carter RN, et al. JMJD6 promotes self-renewal and regenerative capacity of hematopoietic stem cells. Blood Adv. 2021;5(3):889-899.
2020
Yasuda H, Morishita S, Mori Y, Tsukune Y, Inano T, Harada S, Komatsu N. JAK2/CALR/SF3B1 triple-mutated myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis evolving to myelofibrosis and SF3B1 single-mutated acute myeloid leukemia: Evidence of a pre-JAK2 clone. Leuk Res. 2020;100:106496.
Wu W, Fu J, Gu Y, Wei Y, Ma P, Wu J. JAK2/STAT3 regulates estrogen-related senescence of bone marrow stem cells. J Endocrinol. 2020.
Rojas P, Sarmiento M. JAK/STAT Pathway Inhibition May Be a Promising Therapy for COVID-19-Related Hyperinflammation in Hematologic Patients. Acta Haematol. 2020:1-5.
Turaga SM, Silver DJ, Bayik D, Paouri E, Peng S, Lauko A, Alban TJ, Borjini N, Stanko S, Naik U, et al. JAM-A functions as a female microglial tumor suppressor in glioblastoma. Neuro Oncol. 2020.
Kita S, Shimomura I. JB Special Review - Stimulation of exosome biogenesis by adiponectin, a circulating factor secreted from adipocytes. J Biochem. 2020.
Staehle HF, Heinemann J, Gruender A, Omlor AM, Pahl HLuise, Jutzi JSamuel. Jmjd1c is dispensable for healthy adult hematopoiesis and Jak2V617F-driven myeloproliferative disease initiation in mice. PLoS One. 2020;15(2):e0228362.
Li Z, Xu J, Lang Y, Fan X, Kuo L, D'Brant L, Hu S, Samrat S, Trudeau N, Tharappel A, et al. JMX0207, a niclosamide derivative with improved pharmacokinetics, suppresses Zika virus infection both in vitro and in vivo. ACS Infect Dis. 2020.
2019
Kong X, Gong Z, Zhang L, Sun X, Ou Z, Xu B, Huang J, Long D, He X, Lin X, et al. JAK2/STAT3 signaling mediates IL-6-inhibited neurogenesis of neural stem cells through DNA demethylation/methylation. Brain Behav Immun. 2019.
Sayoc-Becerra A, Krishnan M, Fan S, Jimenez J, Hernandez R, Gibson K, Preciado R, Butt G, McCole DF. The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction. Inflamm Bowel Dis. 2019.
Dolatabadi S, Jonasson E, Lindén M, Fereydouni B, Bäcksten K, Nilsson M, Martner A, Forootan A, Fagman H, Landberg G, et al. JAK-STAT signalling controls cancer stem cell properties including chemotherapy resistance in myxoid liposarcoma. Int J Cancer. 2019.
Cyranoski D. Japan poised to allow 'reprogrammed' stem-cell therapy for damaged corneas. Nature. 2019.
Sawai T, Hatta T, Fujita M. Japan Significantly Relaxes Its Human-Animal Chimeric Embryo Research Regulations. Cell Stem Cell. 2019;24(4):513-514.
Efimova MV, Mukhamatdinova EA, Kovtun IS, Kabil FF, Medvedeva YV, Kuznetsov VV. Jasmonic Acid Enhances the Potato Plant Resistance to the Salt Stress in Vitro. Dokl Biol Sci. 2019;488(1):149-152.
Cao P-L, Kumagai N, Inoue T, Agata K, Makino T. JmjC domain-encoding genes are conserved in highly regenerative metazoans and are associated with planarian whole-body regeneration. Genome Biol Evol. 2019.
Guilak F, Sandell L, Huard J. Journal of Orthopaedic Research: Special Issue on Stem Cells. J Orthop Res. 2019.
Radulovic V, van der Garde M, Koide S, Sigurdsson V, Lang S, Kaneko S, Miharada K. Junctional Adhesion Molecule 2 Represents a Subset of Hematopoietic Stem Cells with Enhanced Potential for T Lymphopoiesis. Cell Rep. 2019;27(10):2826-2836.e5.
Tanos V, Balami S, Lingwood L. Junctional zone endometrium alterations in gynecological and obstetrical disorders and impact on diagnosis, prognosis and treatment. Curr Opin Obstet Gynecol. 2019.
2018
Zhang Y, Lin CHua Sarah, Kaushansky K, Zhan H. JAK2V617F Megakaryocytes Promote Hematopoietic Stem/Progenitor Cell Expansion in Mice through Thrombopoietin/MPL signaling. Stem Cells. 2018.
Forbes LR, Vogel TP, Cooper MA, Castro-Wagner J, Schussler E, Weinacht KG, Plant AS, Su HC, Allenspach EJ, Slatter M, et al. Jakinibs for the Treatment of Immunodysregulation in Patients with Gain of Function STAT1 or STAT3 Mutations. J Allergy Clin Immunol. 2018.
Celik H, Koh WKyun, Kramer AC, Ostrander EL, Mallaney C, Fisher DAC, Xiang J, Wilson WC, Martens A, Kothari A, et al. JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor Cells. Cancer Cell. 2018;34(5):741-756.e8.
2016
Langabeer SE, Haslam K. The JAK2 V617F mutation and thrombocytopenia. Hematol Oncol Stem Cell Ther. 2016.
Ojha R, Singh SK, Bhattacharyya S. JAK-mediated Autophagy Regulates Stemness and Cell Survival in Cisplatin Resistant Bladder Cancer Cells. Biochim Biophys Acta. 2016.
Lei X, Xu J-F, Chang R-M, Fang F, Zuo C-H, Yang L-Y. JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling. Oncotarget. 2016.
Castagnini F, Pellegrini C, Perazzo L, Vannini F, Buda R. Joint sparing treatments in early ankle osteoarthritis: current procedures and future perspectives. J Exp Orthop. 2016;3(1):3.

Pages